Abstract
Cardiogenic shock (CS) at the acute stage of MI remains a major concern. Information on its incidence over the past 20 years is discrepant, and little is known of the evolution of long-term mortality over the years. We analysed the incidence and one-year mortality of CS in 4 nationwide French survey carried out 5 years apart from 1995 to 2010. Consecutive STEMI and NSTEMI patients (≤48 hours from onset) were recruited over one-month periods. Among 10610 patients included in the 4 surveys, 614 (5.8%) had CS. Incidence of CS decreased (6.9% in 1995; 4.0% in 2010, p<0.001), both for STEMI and NSTEMI. Pts with CS were older than those without (74±12 vs 66±14y); mean age of CS pts remained unchanged. In CS pts, use of PCI increased from 20% to 73%, and in STEMI patients with CS, reperfusion therapy increased from 40% to 72%. Thirty-day mortality (56.2% vs 4.3%) and one-year mortality (66.6% vs 10.3%) were considerably higher in CS pts. Over the 15-year period, one-year mortality decreased for both pts with (75% to 51%, P<0.001) and without CS (15% to 7%, P<0.001). By Cox multivariate analysis in the whole population, both time period and presence of CS were independent predictors of one-year mortality. In CS pts, age, diabetes, higher BMI and type of MI (STEMI), were independent correlates of increased one-year death, while time period was associated with reduced mortality (HR:2010 vs 1995=0.57; 95% CI: 0.40-0.83, along with early use of PCI and medications at the acute stage. In these 4 nationwide surveys conducted 15 years apart, the incidence of CS decreased and one-year mortality of CS patients significantly decreased. Although improved survival was associated with a broader use of PCI and appropriate medications at the acute stage, the fact that time period remained an independent predictor of improved outcomes suggests improved overall process of care.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have